CRISPR's gene editing therapy finds cure for blood cancer
STAT - 05-Dec-2020Early data from Vertex & CRISPR showed promising results to cure blood disorders
Join the club for FREE to access the whole archive and other member benefits.
Senior Writer at stat news
Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. A veteran journalist, Adam was Senior Columnist at TheStreet, where he wrote about biotech and drug stocks.
Visit website: https://www.statnews.com/staff/adam-feuerstein/
See also: STAT - Media company focussed on health, medicine, and scientific discovery
Details last updated 07-Dec-2020
Early data from Vertex & CRISPR showed promising results to cure blood disorders